Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management

C Gholam, S Grigoriadou, KC Gilmour… - Clinical & …, 2011 - academic.oup.com
Familial haemophagocytic lymphohistiocytosis (FHL) is a rare autosomal recessive disorder
of immune dysregulation associated with uncontrolled T cell and macrophage activation and …

[HTML][HTML] Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients

SJ Howe, MR Mansour… - The Journal of …, 2008 - Am Soc Clin Investig
X-linked SCID (SCID-X1) is amenable to correction by gene therapy using conventional
gammaretroviral vectors. Here, we describe the occurrence of clonal T cell acute …

[HTML][HTML] Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development

F Otto, AP Thornell, T Crompton, A Denzel, KC Gilmour… - Cell, 1997 - cell.com
We have generated Cbfa1-deficient mice. Homozygous mutants die of respiratory failure
shortly after birth. Analysis of their skeletons revealed an absence of osteoblasts and bone …

Engineered bacteriophages for treatment of a patient with a disseminated drug-resistant Mycobacterium abscessus

RM Dedrick, CA Guerrero-Bustamante, RA Garlena… - Nature medicine, 2019 - nature.com
A 15-year-old patient with cystic fibrosis with a disseminated Mycobacterium abscessus
infection was treated with a three-phage cocktail following bilateral lung transplantation …

Gene therapy of X-linked severe combined immunodeficiency by use of a pseudotyped gammaretroviral vector

HB Gaspar, KL Parsley, S Howe, D King, KC Gilmour… - The Lancet, 2004 - thelancet.com
Background X-linked severe combined immunodeficiency (SCID-X1) is caused by mutations
in the common cytokine-receptor γchain (γc), resulting in disruption of development of T …

Genomic diagnosis and care co-ordination for monogenic inflammatory bowel disease in children and adults: consensus guideline on behalf of the British Society of …

J Kammermeier, CA Lamb, KDJ Jones… - The Lancet …, 2023 - thelancet.com
Genomic medicine enables the identification of patients with rare or ultra-rare monogenic
forms of inflammatory bowel disease (IBD) and supports clinical decision making. Patients …

Enhanced CAR T cell expansion and prolonged persistence in pediatric patients with ALL treated with a low-affinity CD19 CAR

S Ghorashian, AM Kramer, S Onuoha, G Wright… - Nature medicine, 2019 - nature.com
Chimeric antigen receptor (CAR)-modified T cells targeting CD19 demonstrate unparalleled
responses in relapsed/refractory acute lymphoblastic leukemia (ALL),,,–, but toxicity …

X-linked lymphoproliferative disease due to SAP/SH2D1A deficiency: a multicenter study on the manifestations, management and outcome of the disease

C Booth, KC Gilmour, P Veys… - Blood, The Journal …, 2011 - ashpublications.org
X-linked lymphoproliferative disease (XLP1) is a rare immunodeficiency characterized by
severe immune dysregulation and caused by mutations in the SH2D1A/SAP gene. Clinical …

A prospective evaluation of degranulation assays in the rapid diagnosis of familial hemophagocytic syndromes

YT Bryceson, D Pende, A Maul-Pavicic… - Blood, The Journal …, 2012 - ashpublications.org
Familial hemophagocytic lymphohistiocytosis (FHL) is a life-threatening disorder of immune
regulation caused by defects in lymphocyte cytotoxicity. Rapid differentiation of primary …

Hematopoietic stem cell gene therapy for adenosine deaminase–deficient severe combined immunodeficiency leads to long-term immunological recovery and …

HB Gaspar, S Cooray, KC Gilmour, KL Parsley… - Science translational …, 2011 - science.org
Genetic defects in the purine salvage enzyme adenosine deaminase (ADA) lead to severe
combined immunodeficiency (SCID) with profound depletion of T, B, and natural killer cell …